Lipocine Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2013 | FY2012 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $7.7M |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | $11.0M | $8.1M | $5.1M | $2.3M |
| SG&A Expense | $10.2M | $10.4M | $3.6M | $1.6M |
| Operating Income | $-21.2M | $-19.2M | $-10.7M | $3.9M |
| Operating Margin | — | — | — | 50.3% |
| Interest Expense | — | — | — | — |
| Pretax Income | $-21.0M | $-19.0M | $-10.6M | $3.9M |
| Income Tax Expense | $700 | $752 | $-55.0K | $684 |
| Net Income | $-21.0M | $-19.0M | $-10.6M | $3.9M |
| Net Margin | — | — | — | 50.4% |
| EPS (Basic) | $-0.53 | $-0.52 | $-0.72 | $0.43 |
| EPS (Diluted) | $-0.53 | $-0.52 | $-0.72 | $0.43 |
| Shares Outstanding (Basic) | 40.1M | 36.5M | 14.7M | 8.9M |
| Shares Outstanding (Diluted) | 40.1M | 36.5M | 14.7M | 8.9M |
| Dividends Per Share | — | — | — | — |